Carnitine deficiency: Risk factors and incidence in children with epilepsy

Brain and Development

Volumn 37, Issue 8, 2015, Pages 790-796

  Fukuda, Mitsumasa ^a   Kawabe, Mika ^a   Takehara, Makoto ^a   Iwano, Sachiko ^a   Kuwabara, Kozue ^b   Kikuchi, Chiya ^b   Wakamoto, Hiroyuki ^b   Morimoto, Takehiko ^b   Suzuki, Yuka ^b   Ishii, Eiichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Ehime Rehabilitation Center for Children   (Japan)

Author keywords

Antiepileptic drugs; Carnitine deficiency; Childhood epilepsy; Estimated formula; Intellectual disability; Tube feeding

Indexed keywords

CARNITINE; VALPROIC ACID; ANTICONVULSIVE AGENT;

ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CARNITINE DEFICIENCY; CHILD; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG USE; ENTERIC FEEDING; ENZYME METABOLISM; EPILEPSY; FEMALE; FOOD INTAKE; GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; ADOLESCENT; BLOOD; CARDIOMYOPATHY; CASE CONTROL STUDY; DEFICIENCY; DIET THERAPY; HYPERAMMONEMIA; INCIDENCE; INFANT; JAPAN; KETOGENIC DIET; MUSCLE DISEASE; PRESCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; CARDIOMYOPATHIES; CARNITINE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; HYPERAMMONEMIA; INCIDENCE; INFANT; JAPAN; KETOGENIC DIET; MALE; MUSCULAR DISEASES; RISK FACTORS; VALPROIC ACID;

EID: 84939251555     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2014.12.004     Document Type: Article

References (22)

1. Pons R., Carrozzo R., Tein I., Walker W.F., Addonizio L.J., Rhead W., et al. Deficient muscle carnitine transport in primary carnitine deficiency. Pediatr Res 1997, 42:583-587.
2. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J 1992, 6:3379-3386.
3. De Vivo D.C., Tein I. Primary and secondary disorders of carnitine metabolism. Int Pediatr 1990, 5:134-141.
4. Castro-Gago M., Eiris-Puñal J., Novo-Rodriguez M.I., Couceiro J., Camiña F., Rodriguez-Segade S. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. J Child Neurol 1998, 13:546-549.
5. Hiraoka A., Arato T., Tominaga I. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs. Biol Pharm Bull 1997, 20:91-93.
6. Verrotti A., Greco R., Morgese G., Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999, 29:36-40.
7. Coulter D.L. Carnitine deficiency in epilepsy: risk factors and treatment. J Child Neurol 1995, 10:S32-9.
8. Takahashi M., Ueda S., Misaki H., Sugiyama N., Matsumoto K., Matsuo N., et al. Carnitine determination by an enzymatic cycling method with carnitine dehydrogenase. Clin Chem 1994, 40:817-821.
9. Palisano R., Rosenbaum P., Walter S., Russell D., Wood E., Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997, 39:214-223.
10. Graham H.K. Classifying cerebral palsy. J Pediatr Orthop 2005, 25:127-128.
11. Tanaka S., Miki T., Hsieh S.T., Kim J.I., Yasumoto T., Taniguchi T., et al. A case of severe hyperlipidemia caused by long-term tube feedings. J Atheroscler Thromb 2003, 10:321-324.
12. Castro-Gago M., Camiña F., Rodriguez-Segade S. Carnitine deficiency caused by valproic acid. J Pediatr 1992, 120:496.
13. Coulter D.L. Carnitine, valproate, and toxicity. J Child Neurol 1991, 6:7-14.
14. Nakajima Y., Ito T., Maeda Y., Ichiki S., Kobayashi S., Ando N., et al. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS. Brain Dev 2011, 33:816-823.
15. Silva M.F., Selhorst J., Overmars H., van Gennip A.H., Maya M., Wanders R.J., et al. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Clin Biochem 2001, 34:635-638.
16. Werner T., Treiss I., Kohlmueller D., Mehlem P., Teich M., Longin E., et al. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Epilepsia 2007, 48:72-76.
17. Maeda Y., Ito T., Suzuki A., Kurono Y., Ueta A., Yokoi K., et al. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:799-806.
18. Opala G., Winter S., Vance C., Vance H., Hutchison H.T., Linn L.S. The effect of valproic acid on plasma carnitine levels. Am J Dis Child 1991, 145:999-1001.
19. Takeda Y., Kubota M., Sato H., Nagai A., Higashiyama Y., Kin H., et al. Carnitine in severely disabled patients: relation to anthropometric, biochemical variables, and nutritional intake. Brain Dev 2015, 37:94-100.
20. Hamed S.A., Abdella M.M. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Epilepsy Res 2009, 86:32-41.
21. Beghi E., Bizzi A., Codegoni A.M., Trevisan D., Torri W. Valproate, carnitine metabolism, and biochemical indicators of liver function. Collaborative Group for the study of epilepsy. Epilepsia 1990, 31:346-352.
22. De Vivo D.C., Bohan T.P., Coulter D.L., Dreifuss F.E., Greenwood R.S., Nordli D.R., et al. l-carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia 1998, 39:1216-1225.